The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Miltenyi Biotec sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Miltenyi Biotec is a supplier of products and solutions for biomedical research and advanced cellular therapy. The company offers cell research, cell therapy, and cell manufacturing solutions to the researchers and medical practitioners worldwide. Its products are used in various therapy areas such as, immunology, stem cell biology, neuroscience, and cancer. The company has various partnerships to market products worldwide. Miltenyi Biotec is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany. Key subsidiaries of Miltenyi Biotec include Miltenyi Biotec and Miltenyi Biomedicine.
The key metrics of Miltenyi Biotec related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Miltenyi Biotec is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Miltenyi Biotec.
For a detailed understanding of the performance of Miltenyi Biotec, buy the report here.